This inventor holds 7 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag. Active years: 2016-2024.
Company Filing History:
3 out of 3,736 
2 out of 5,020 
1 out of 180 
Years Active: 2016-2024
Title: The Innovative Contributions of Andrew F. Donnell
Introduction
Andrew F. Donnell is a notable inventor based in West Windsor, NJ, who has made significant contributions to the field of medical science. His work primarily focuses on developing novel compounds that can be utilized in the treatment of serious health conditions.
Latest Patents
Donnell holds a patent for NLRP3 modulators, which are compounds designed to modulate the NLRP3 protein. This invention is particularly relevant for treating proliferative disorders, including cancer, in subjects such as humans. The patent outlines compounds of Formula (I), where all variables are defined, showcasing the innovative nature of his work.
Career Highlights
Throughout his career, Andrew F. Donnell has been associated with Innate Tumor Immunity, Inc., where he has been instrumental in advancing research and development in tumor immunity. His expertise and dedication have positioned him as a key figure in the field.
Collaborations
Donnell has collaborated with talented individuals such as Yong Zhang and Ashvinikumar V. Gavai, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Andrew F. Donnell's contributions to the field of medical science through his patent on NLRP3 modulators highlight his commitment to addressing critical health challenges. His work continues to inspire advancements in cancer treatment and immunology.